{
  "id": 463655,
  "title": "Study suggests experimental drug dismantles 2 key proteins that help tumors survive, adapt and resist treatment",
  "url": "https://urgent.news/2026/08/10/study-suggests-experimental-drug-dismantles-2-key-proteins-that-help",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-10T11:20:03.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-08-experimental-drug-dismantles-key-proteins.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Scientists from Roswell Park Comprehensive Cancer Center report that the investigational anticancer agent FL118 functions as a dual molecular glue degrader that directly targets and degrades the proteins DDX5 and UbE2T, two emerging therapeutic targets linked to cancer survival mechanisms.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}